Pulmonx Corp 8-K Filing
Ticker: LUNG · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Pulmonx Corp (ticker: LUNG) to the SEC on Nov 12, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ange on which registered Common Stock, $0.001 par value LUNG The Nasdaq Stock Market).
How long is this filing?
Pulmonx Corp's 8-K filing is 2 pages with approximately 516 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-11-12 16:05:04
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value LUNG The Nasdaq Stock Market
Filing Documents
- lung-20251112.htm (8-K) — 27KB
- lung3q25earningsrelease111.htm (EX-99.1) — 139KB
- pulmonxlogoa.jpg (GRAPHIC) — 8KB
- 0001127537-25-000058.txt ( ) — 302KB
- lung-20251112.xsd (EX-101.SCH) — 2KB
- lung-20251112_lab.xml (EX-101.LAB) — 21KB
- lung-20251112_pre.xml (EX-101.PRE) — 12KB
- lung-20251112_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On November 12, 2025, Pulmonx Corporation (the "Company") issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2025. A copy of the Company's press release dated November 12, 2025, titled "Pulmonx Reports Third Quarter 2025 Financial Results" is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information (including the exhibit hereto) is being furnished under "Item 2.02 Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated November 12, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pulmonx Corporation Dated: November 12, 2025 By: /s/ Derrick Sung Derrick Sung Chief Financial Officer